FRANKFURT, Germany & LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that it has entered into a loan agreement dated April 26, 2023 (the “Loan Agreement”) with Veridia Canada Ltd. (the “Lender”), in the principal amount of €500,000 (approximately C$738,650) (the “Loan”), which has been advanced in full by the Lender. The Loan is expected to be used for the short-term financial commitments of Akanda an
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of First Drug Candidate for Cannabis Use Disorder
- Flora Growth Corp. to Effect Reverse Stock Split
- Canopy Growth Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- Rapid Dose Announces Proposed Private Placement Financing
- Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
More from this user
